Cell Culture Reagents Market Poised for Significant Growth, Projected to Reach $12.8 Billion by 2029

City, Date - Meticulous Research®, a leading provider of market insights, unveils its latest forecast indicating a promising outlook for the global cell culture reagents market. The market is expected to experience robust growth, with a projected Compound Annual Growth Rate (CAGR) of 12.8% from 2022 to 2029, reaching a substantial value of $11.04 billion by the end of the forecast period. This projection underscores the escalating demand for cell culture reagents driven by various factors.

Cell culture reagents serve as essential supplements for the in-vitro growth and development of cells, playing critical roles in maintaining salt concentration, cell adhesion, cryopreservation, and more. These reagents encompass a wide array of products including growth factors and cytokines, cryoprotective agents, antibiotics, cell dissociation reagents, and buffers & chemicals, among others.

Download Sample Copy: https://www.meticulousresearch.com/download-sample-report/cp_id=5322

Impact of COVID-19 Pandemic

The COVID-19 pandemic has significantly influenced the cell culture reagents market landscape. As researchers worldwide engaged in studies to understand the biology of the virus and develop therapeutic interventions, in vitro cell culture models emerged as vital tools for COVID-19 research. Human lung epithelium models and other cell culture models played pivotal roles in various areas of COVID-19 research, including antiviral research, vaccine development, and pathogenesis studies. Consequently, the pandemic positively impacted the growth of the cell culture reagents market.

Market Segmentation

The global cell culture reagents market is segmented by product, application, end user, and geography. Key segments include growth factors and cytokines, cryoprotective reagents, bioproduction, diagnostics, pharmaceutical & biotechnology companies, and academic & research institutes, among others.

Product Segment: In 2022, the growth factors and cytokines segment is anticipated to dominate the market, driven by pharmaceutical & biotechnological companies' focus on serum-free media.

Speak to Analyst: https://www.meticulousresearch.com/speak-to-analyst/cp_id=5322

Application Segment: The bioproduction segment is expected to lead the market, attributed to the rising demand for biopharmaceutical products such as monoclonal antibodies, vaccines, and therapeutic proteins.

End User Segment: Pharmaceutical & biotechnology companies are estimated to account for the largest share of the market, supported by increased R&D spending and expansion of production facilities.

Geographic Analysis

North America is expected to dominate the global market, owing to a well-established healthcare system, advanced technologies, and ongoing capacity expansion by biopharmaceutical manufacturers. However, Asia-Pacific is projected to witness the highest CAGR during the forecast period, driven by growing investments in healthcare infrastructure and research activities.

Buy this Report: https://www.meticulousresearch.com/Checkout/27729215

Key Players

The global cell culture reagents market is characterized by the presence of key players such as Merck KGaA, Thermo Fisher Scientific Inc., Cytiva, Lonza Group Ltd, and others.

About Us:
We are the trusted research partners for leading businesses around the world, providing market intelligence focused towards building revenue transformation strategies. Our research is used by Fortune 500 organizations to attain success by scouting next generation revenue opportunities well ahead of their competition.

Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research

This release was published on openPR.